Skip to content

Theracal Pulpotomy in Primary Molars

Theracal Versus Formocresol Pulpotomy in Primary Molars

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04397094
Enrollment
60
Registered
2020-05-21
Start date
2017-12-01
Completion date
2019-03-30
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Caries

Keywords

Theracal, formocresol, pulpotomy

Brief summary

Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol pulpotomy in primary molars.

Detailed description

sixty primary molars were either treated with Theracal LC or formocresol pulpotomy. Teeth were followed up clinicaly and radiographically for 12 months.

Interventions

pulpotomy

Pulpotomy

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 7 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy, cooperative children * mandibular primary molars with vital pulp exposures

Exclusion criteria

* clinical or radiographic evidence of irreversible pulpitis * physiological root resorption

Design outcomes

Primary

MeasureTime frameDescription
Clinical Examination12 monthsNumber of participants with tooth mobility, restoration loss, gingival swelling/fistula, pain on percussion.

Secondary

MeasureTime frameDescription
Radiographic Examination12 monthsNumber of participants showing teeth with inter-radicular bone resorption, periapical bone resorption, internal root resorption, external root resorption, widening of periodontal ligament space.

Countries

Egypt

Participant flow

Participants by arm

ArmCount
Theracal LC
Theracal LC was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months. Theracal LC: pulpotomy
30
Formocresol
Formocresol (1/5 th concentration) was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months. Formocresol: Pulpotomy
30
Total60

Baseline characteristics

CharacteristicTotalTheracal LCFormocresol
Age, Categorical
<=18 years
60 Participants30 Participants30 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous5.61 years
STANDARD_DEVIATION 0.55
5.71 years
STANDARD_DEVIATION 0.59
5.56 years
STANDARD_DEVIATION 0.71
Race and Ethnicity Not Collected0 Participants
radiographic and clinical examinations8 participants3 participants5 participants
Region of Enrollment
Egypt
60 Participants30 Participants30 Participants
Sex: Female, Male
Female
28 Participants13 Participants15 Participants
Sex: Female, Male
Male
32 Participants17 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 30
other
Total, other adverse events
3 / 305 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Clinical Examination

Number of participants with tooth mobility, restoration loss, gingival swelling/fistula, pain on percussion.

Time frame: 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Theracal LCClinical Examination30 Participants
FormocresolClinical Examination30 Participants
Secondary

Radiographic Examination

Number of participants showing teeth with inter-radicular bone resorption, periapical bone resorption, internal root resorption, external root resorption, widening of periodontal ligament space.

Time frame: 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Theracal LCRadiographic Examination30 Participants
FormocresolRadiographic Examination30 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026